Moderna reported second-quarter 2026 revenue of $145 million, topping expectations. However, cash and cash equivalents fell to $6.9 billion from $7.5 billion at the end of March, mainly after a $950 million litigation settlement payment in July. R&D spending declined 7% year over year as several late-stage programs wound down. The company reaffirmed its full-year 2026 sales guidance and said it expects roughly 50% of revenue to come from international markets, but the stock fell Friday as investors focused on liquidity pressure from the large cash outflow.

Aarti Drugs reported net profit of ₹50.17 crore for the first quarter of FY2024, down 6.9% year on year, even as revenue rose 19% to ₹702.78 crore. EBITDA increased 32.6% to ₹98.20 crore and the EBITDA margin improved to 13.97%. The company also named Adhish P. Patil as Managing Director for a five-year term effective October 1, 2026, subject to shareholder approval at the next Annual General Meeting.

Maruti Suzuki reported a 36% year-on-year rise in quarterly revenue to 4995.9 billion rupees, while profit attributable to the parent fell 27.1% to 35.788 billion rupees. Its EBITDA margin narrowed to 26.7% from 31.7%. Bajaj Finance posted a strong quarter with profit up 28%, adding 5.1 million customers and disbursing more than 16 million new loans. Bajaj Finserv’s consolidated net profit rose 18% to 62.97 billion rupees, and net interest income increased 20% to 145.28 billion rupees.

Concord Biotech reported fiscal 2024 first-quarter results for the period ended June 30, with net profit rising 33% year on year to ₹58.5 crore. Revenue from operations increased 26.2% to ₹257.4 crore. EBITDA climbed to ₹82.4 crore and the EBITDA margin improved to 32% from 30.1% a year earlier. The results point to stronger operating efficiency alongside improved margins.

Novo Nordisk shares slid, wiping $30.7 billion from the company’s market capitalization in a single session and leaving it down nearly 69% from its June 2024 peak. The company is pushing to commercialize oral versions of its GLP-1 medicines, having launched a Wegovy pill in the United Arab Emirates and the U.K. with plans to sell in the U.S. and globally. It has also entered a public dispute with Eli Lilly over the accuracy of advertising claims. The moves and the clash are part of intensifying competition in obesity and diabetes drugs, adding near-term pressure to biopharma-focused index tools such as ONUS.

India’s Securities and Exchange Board of India (SEBI) said exchanges will adopt a new Closing Auction Session (CAS) from Aug. 3, 2026, replacing the current 30-minute VWAP-based closing mechanism. The 20-minute CAS will run from 15:15 to 15:35 and is designed to produce a single equilibrium closing price to improve fairness and price discovery. The change is intended to curb “marking the close” and strengthen settlement protection for retail and passive investors. The rule will apply to constituents of domestic equity indices and related derivatives contracts.

Severe drought across parts of Europe has pushed major rivers to unusually low levels, cutting electricity output and straining inland transport networks. At Serbia’s Djerdap 1 hydropower plant on the Danube, generation has dropped to 20% of capacity, while shipping constraints have reduced inland cargo volumes linked to Rotterdam by about 10% versus normal. In Italy, regional utility A2A expects hydropower production of 3.9 TWh this year, below a historical average of 4.1 TWh. The disruption is affecting power supply and river logistics at the same time, adding pressure to electricity markets and energy systems.

Afreximbank has provided US$190 million in financing to Zimbabwe’s CBZ Bank, including a US$150 million revolving trade finance facility and a US$20 million SME-focused facility. The package is designed to help narrow Africa’s trade finance gap and strengthen CBZ’s capacity to extend credit to local export-oriented small and medium-sized businesses. The deal is positioned as regional development finance cooperation and does not directly involve tradable assets in global traditional financial markets.